Share
Market Research Report

MENINGOCOCCAL VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By TypePolysaccharide Vaccines · Conjugate Vaccines · Combination Vaccines · Other
  • By Sales ChannelPublic and Private
  • By Age GroupInfants and Children and Adults
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In03 Apr 2026
  • Report CodeCMI3864
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Type
      • Market Snapshot, By Sales Channel
      • Market Snapshot, By Age Group
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Acquisitions and Partnerships Scenario
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. Global Meningococcal Vaccines Market, By Type, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
    • Polysaccharide Vaccines
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Conjugate Vaccines
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Combination Vaccines
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  5. Global Meningococcal Vaccines Market, By Sales Channel, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
    • Public
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Private
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  6. Global Meningococcal Vaccines Market, By Age Group, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
    • Infants (0 to 2 years)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Children and Adults (2 years & above)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  7. Global Meningococcal Vaccines Market, By Region, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2021–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Company Profiles
      • GlaxoSmithKline plc
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Pfizer Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sanofi Pasteur
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Merck & Co., Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Serum Institute of India Pvt. Ltd.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Walvax Biotechnology Co., Ltd.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Hualan Biological Engineering Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • JN-International Medical Corporation
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Beijing Minhai Biotechnology Co., Ltd
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bio-Manguinhos/Fiocruz
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Chongqing Zhifei Biological Products Co., Ltd.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Baxter International
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • CSL Limited
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bavarian Nordic
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Incepta Vaccine Ltd.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sinovac Biotech Ltd.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Novartis
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Panacea Biotec Ltd
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  9. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  10. References and Research Methodology


    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 28 figures on "Meningococcal Vaccines Market” - Global forecast to 2033